Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels

Multicentric Castleman Disease is largely driven by increased signaling in the pathway for the plasma cell growth factor interleukin-6. We hypothesized that interleukin-6/interleukin-6 receptor/gp130 polymorphisms contribute to increased interleukin-6 and/or other components of the interleukin-6 sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Stone, Katie, Woods, Emily, Szmania, Susann M., Stephens, Owen W., Garg, Tarun K., Barlogie, Bart, Shaughnessy, John D., Hall, Brett, Reddy, Manjula, Hoering, Antje, Hansen, Emily, van Rhee, Frits
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553080/
https://www.ncbi.nlm.nih.gov/pubmed/23372742
http://dx.doi.org/10.1371/journal.pone.0054610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553080/
https://www.ncbi.nlm.nih.gov/pubmed/23372742
http://dx.doi.org/10.1371/journal.pone.0054610

Ejemplares similares